Maze Therapeutics logo

Maze Therapeutics

BrandBiotechnology ResearchSouth San Francisco, CaliforniaWebsite

Company Overview

Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. The company’s pipeline is led by two wholly owned lead programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease. Maze is based in South San Francisco.
Founded
2018
Headquarters
South San Francisco, California
Employees
51-200
8.8% growth last 12mo
Culture / Work-Life Signal
Overall rating
4.4 / 5
Work-life balance
4.1 / 5
Culture
4.5 / 5
Diversity & inclusion
4.6 / 5
Recommend to a friend
87%
Positive business outlook
82%

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Hiring Activity

Open Marketing Jobs Over Time

Historical trend of active job postings

Salaries

Community Salary Data

Help build salary transparency at Maze Therapeutics. Share your compensation anonymously.

Contribute

Reviews

Founders

News

Jobs